These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32214478)

  • 1. Virus-Like Particles as an Instrument of Vaccine Production.
    Syomin BV; Ilyin YV
    Mol Biol; 2019; 53(3):323-334. PubMed ID: 32214478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Virus-Like Particles as an Instrument of Vaccine Production].
    Syomin BV; Ilyin YV
    Mol Biol (Mosk); 2019; 53(3):367-379. PubMed ID: 31184601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant-derived virus-like particles as vaccines.
    Chen Q; Lai H
    Hum Vaccin Immunother; 2013 Jan; 9(1):26-49. PubMed ID: 22995837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-like Particle Vaccines and Platforms for Vaccine Development.
    Kheirvari M; Liu H; Tumban E
    Viruses; 2023 May; 15(5):. PubMed ID: 37243195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
    Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus like particles as a platform for cancer vaccine development.
    Ong HK; Tan WS; Ho KL
    PeerJ; 2017; 5():e4053. PubMed ID: 29158984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudotyping Improves the Yield of Functional SARS-CoV-2 Virus-like Particles (VLPs) as Tools for Vaccine and Therapeutic Development.
    Zak AJ; Hoang T; Yee CM; Rizvi SM; Prabhu P; Wen F
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference.
    Engeroff P; Bachmann MF
    Expert Rev Vaccines; 2019 Jan; 18(1):1-3. PubMed ID: 30526126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses.
    Janitzek CM; Matondo S; Thrane S; Nielsen MA; Kavishe R; Mwakalinga SB; Theander TG; Salanti A; Sander AF
    Malar J; 2016 Nov; 15(1):545. PubMed ID: 27825348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric Virus-like Particles of Universal Antigen Epitopes of Coronavirus and Phage Qβ Coat Protein Trigger the Production of Neutralizing Antibodies.
    Guo Y; Guo R; Ma Y; Chang W; Ming S; Yang G; Guo Y
    Curr Top Med Chem; 2021 Oct; 21(14):1235-1250. PubMed ID: 34145995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid screening and scaled manufacture of immunogenic virus-like particles in a tobacco BY-2 cell-free protein synthesis system.
    Armero-Gimenez J; Wilbers R; Schots A; Williams C; Finnern R
    Front Immunol; 2023; 14():1088852. PubMed ID: 36776898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
    Ramirez A; Morris S; Maucourant S; D'Ascanio I; Crescente V; Lu IN; Farinelle S; Muller CP; Whelan M; Rosenberg W
    Vaccine; 2018 Feb; 36(6):873-880. PubMed ID: 29306508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status and future directions of fish vaccines employing virus-like particles.
    Jeong KH; Kim HJ; Kim HJ
    Fish Shellfish Immunol; 2020 May; 100():49-57. PubMed ID: 32130976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus.
    Urakami A; Sakurai A; Ishikawa M; Yap ML; Flores-Garcia Y; Haseda Y; Aoshi T; Zavala FP; Rossmann MG; Kuno S; Ueno R; Akahata W
    Clin Vaccine Immunol; 2017 Jul; 24(7):. PubMed ID: 28515133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric Hepatitis B core virus-like particles harboring SARS-CoV2 epitope elicit a humoral immune response in mice.
    Sazegari S; Akbarzadeh Niaki M; Afsharifar A; Niazi A; Derakhshandeh A; Moradi Vahdat M; Hemmati F; Eskandari MH
    Microb Cell Fact; 2023 Feb; 22(1):39. PubMed ID: 36841778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-like particles as powerful vaccination strategy against human viruses.
    Hadj Hassine I; Ben M'hadheb M; Almalki MA; Gharbi J
    Rev Med Virol; 2024 Jan; 34(1):e2498. PubMed ID: 38116958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.